CN106730052A - A kind of anticoagulant fimbrin material and preparation method thereof - Google Patents
A kind of anticoagulant fimbrin material and preparation method thereof Download PDFInfo
- Publication number
- CN106730052A CN106730052A CN201710108408.4A CN201710108408A CN106730052A CN 106730052 A CN106730052 A CN 106730052A CN 201710108408 A CN201710108408 A CN 201710108408A CN 106730052 A CN106730052 A CN 106730052A
- Authority
- CN
- China
- Prior art keywords
- silk fibroin
- solution
- polyethylene glycol
- anticoagulant
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
- A61L33/128—Other specific proteins or polypeptides not covered by A61L33/122 - A61L33/126
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0023—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using a quaternized group or a protonated amine group of the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0076—Chemical modification of the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/068—Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
技术领域technical field
本发明属于抗凝血材料技术领域,尤其涉及一种丝素蛋白抗凝血材料及其制备方法。The invention belongs to the technical field of anticoagulant materials, and in particular relates to a silk fibroin anticoagulant material and a preparation method thereof.
背景技术Background technique
我国每年心脑血管疾病死亡人数有数百万,并在逐年增加,因此,血液接触材料是目前临床上最为紧缺的生物材料(医疗器械),尤其是人工血管移植,即便是得到临床应用的中、大口径人工血管,在我国产品也非常稀少,国产产品每年的使用比例只有20%左右,而小口径人工血管的移植还是临床空白,其最大的问题就是容易形成血栓,远期通畅率较差。There are millions of deaths from cardiovascular and cerebrovascular diseases in my country every year, and it is increasing year by year. Therefore, blood-contact materials are currently the most scarce biomaterials (medical devices) in clinical practice, especially artificial blood vessel grafts. , Large-diameter artificial blood vessels are also very rare in my country, and the annual use ratio of domestic products is only about 20%, while the transplantation of small-caliber artificial blood vessels is still a clinical blank. The biggest problem is that it is easy to form thrombus, and the long-term patency rate is poor .
目前医学上应用的人工血管产品主要是由涤纶、膨体聚四氟乙烯等合成材料制成的,在大中口径人工血管方面有临床应用,但这些合成材料细胞相容性差,不利于内皮化,容易形成血栓,影响组织愈合。家蚕蚕丝是由家蚕合成与分泌的天然动物蛋白,来源广泛,其丝素蛋白具有良好的生物相容性,由20种人体可吸收的氨基酸组成,最终降解产物为氨基酸或小肽,易被细胞吸收或吞噬,不会引起明显的免疫反应。已有大量的文献研究表明丝素蛋白材料能够支持多种细胞的生长,在组织工程材料研究方面越来越深入,并取得了突破性的进展,近来,应用于血管组织工程上也越来越受到关注。At present, artificial blood vessels used in medicine are mainly made of synthetic materials such as polyester and expanded polytetrafluoroethylene, which have clinical applications in large and medium-caliber artificial blood vessels, but these synthetic materials have poor cytocompatibility and are not conducive to endothelialization , easy to form thrombus, affecting tissue healing. Bombyx mori silk is a natural animal protein synthesized and secreted by silkworms. It has a wide range of sources. Its silk fibroin has good biocompatibility and is composed of 20 kinds of amino acids that can be absorbed by the human body. The final degradation products are amino acids or small peptides, which are easily absorbed by cells. Absorption or phagocytosis will not cause obvious immune response. A large number of literature studies have shown that silk fibroin materials can support the growth of various cells, and the research on tissue engineering materials has become more and more in-depth, and breakthroughs have been made. Recently, silk fibroin materials are more and more used in vascular tissue engineering. Having attention.
虽然丝素蛋白材料本身具有细胞相容性和组织相容性的优势,但作为外源材料,在与血液接触时都会刺激凝血系统,诱发溶血或凝血。为了提高丝素材料的抗凝血性能,国内外一些研究人员也关注到了改善丝素蛋白材料的抗凝血性能研究。Although silk fibroin material itself has the advantages of cytocompatibility and tissue compatibility, as an exogenous material, it will stimulate the coagulation system and induce hemolysis or coagulation when it comes into contact with blood. In order to improve the anticoagulant performance of silk fibroin materials, some researchers at home and abroad have also paid attention to improving the anticoagulant performance of silk fibroin materials.
目前,对丝素蛋白的抗凝血改性主要报导了接枝具有抗凝作用的高分子及硫酸化或肝素化方法。如She等将肝素在温和的条件下加入丝素/壳聚糖支架中,增强了抗凝性(Polymer International,2010,59(1):55-61);Liu等利用静电纺丝技术将氯磺酸处理过的丝素蛋白制成丝素纳米支架,硫酸化纳米丝素支架的抗凝血性显著增强(Biomaterials,2011,32(15):3784-3793);Wang等利用静电纺丝技术制备了肝素改性丝素纳米材料,体外凝血测试结果表明改性后丝素纳米材料的抗凝血性远高于纯丝素(InternationalJournal of Biological Macromolecules,2011,48(2):345-353);用氯磺酸制备的硫酸化丝素蛋白的抗凝血活性要比硫酸制备的硫酸化丝素大大提高(Biomaterials,2004,25(3):377-383),但远远不及肝素。肝素改性丝素蛋白材料抗凝血性研究已存在知识产权(如抗凝血真皮支架的制备,申请号为CN200910223207.4的中国专利;纳米纤维人工血管及制备方法,申请号为CN200910228843.6的中国专利),所以引入肝素是目前丝素材料抗凝血性改性的主要方法,但肝素属于一种凝血酶间接抑制剂,抗凝作用要依赖抗凝血酶和特定的辅因子,所以即使材料中共混或键合的肝素不一定能或都能发挥抗凝作用。At present, the anticoagulant modification of silk fibroin mainly reports grafting polymers with anticoagulant effect and sulfated or heparinized methods. For example, She et al. added heparin to the silk fibroin/chitosan scaffold under mild conditions to enhance the anticoagulation (Polymer International, 2010,59(1):55-61); Liu et al. Sulfonic acid-treated silk fibroin was used to make silk nano-scaffolds, and the anticoagulant properties of sulfated nano-silk fibroin scaffolds were significantly enhanced (Biomaterials, 2011, 32(15): 3784-3793); Wang et al. prepared by electrospinning technology Heparin-modified silk fibroin nanomaterials, in vitro coagulation test results show that the anticoagulant property of silk fibroin nanomaterials after modification is much higher than that of pure silk fibroin (InternationalJournal of Biological Macromolecules, 2011, 48 (2): 345-353); The anticoagulant activity of the sulfated silk fibroin prepared by chlorosulfonic acid is much higher than that of the sulfated silk fibroin prepared by sulfuric acid (Biomaterials, 2004, 25(3): 377-383), but far inferior to heparin. The research on the anticoagulant properties of heparin-modified silk fibroin materials already has intellectual property rights (such as the preparation of anticoagulant dermal stents, the Chinese patent application number is CN200910223207.4; the nanofiber artificial blood vessel and its preparation method, the application number is CN200910228843.6 Chinese patent), so the introduction of heparin is currently the main method for anticoagulant modification of silk fibroin materials, but heparin is an indirect inhibitor of thrombin, and the anticoagulant effect depends on antithrombin and specific cofactors, so even if the material Blended or bonded heparins may or may not be anticoagulant.
水蛭素是一种凝血酶特异性抑制剂,可以直接抑制血栓形成,还可以对已形成的血栓有一定的溶栓作用。我们已经研究开发了一种水蛭素/丝素蛋白抗凝血材料(一种抗凝血丝素材料及其制备方法,申请号为ZL201310250951.X的中国专利;一种抗凝血丝素膜及其制备方法,申请号为ZL201310251819.0的中国专利;Journal of Biomedical MaterialsResearch Part B,2015:103B:556–562),但深入研究发现,将研究结果与水蛭素抑制凝血酶活性的机理结合起来分析,采用共价键结合的改性方法会降低水蛭素的活性。Hirudin is a specific inhibitor of thrombin, which can directly inhibit the formation of thrombus, and can also have a certain thrombolytic effect on the formed thrombus. We have researched and developed a hirudin/silk fibroin anticoagulant material (an anticoagulant silk fibroin material and its preparation method, the Chinese patent application number is ZL201310250951.X; an anticoagulant silk fibroin film and its preparation method , Chinese patent with application number ZL201310251819.0; Journal of Biomedical Materials Research Part B, 2015:103B:556–562), but in-depth research found that the research results were combined with the mechanism of hirudin’s inhibition of thrombin activity. The modification method of valence bond will reduce the activity of hirudin.
发明内容Contents of the invention
有鉴于此,本发明要解决的技术问题在于提供一种丝素蛋白抗凝血材料及其制备方法,该方法制备的丝素蛋白抗凝血材料可高效抑制凝血酶活性、持续具有抗凝血功能。In view of this, the technical problem to be solved by the present invention is to provide a silk fibroin anticoagulant material and a preparation method thereof. The silk fibroin anticoagulant material prepared by the method can efficiently inhibit thrombin activity and continuously have anticoagulant properties. Function.
本发明提供了一种丝素蛋白抗凝血材料的制备方法,包括以下步骤:The invention provides a preparation method of silk fibroin anticoagulant material, comprising the following steps:
S1)将丝素蛋白溶液、聚乙二醇二胺与交联剂混合,反应后透析,干燥,得到聚乙二醇二胺阳离子化的丝素蛋白材料;S1) Mix the silk fibroin solution, polyethylene glycol diamine and a cross-linking agent, dialyze after the reaction, and dry to obtain a silk fibroin material cationized with polyethylene glycol diamine;
S2)将所述聚乙二醇二胺阳离子化的丝素蛋白材料浸渍于水蛭素溶液中,得到丝素蛋白抗凝血材料。S2) immersing the polyethylene glycol diamine cationized silk fibroin material in a hirudin solution to obtain a silk fibroin anticoagulant material.
优选的,所述丝素蛋白溶液的质量浓度为3%~20%。Preferably, the mass concentration of the silk fibroin solution is 3%-20%.
优选的,所述聚乙二醇二胺的质量与丝素蛋白溶液中丝素蛋白的质量比为A,0<A≤0.5。Preferably, the mass ratio of the polyethylene glycol diamine to the silk fibroin in the silk fibroin solution is A, 0<A≤0.5.
优选的,所述交联剂选自1-(3-二甲氨基丙基)-3-乙基碳二亚胺、N-羟基琥珀酰亚胺、2-吗啉乙磺酸、碳化二亚胺、京尼平与聚乙二醇甘油醚中的一种或多种。Preferably, the crosslinking agent is selected from 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, N-hydroxysuccinimide, 2-morpholineethanesulfonic acid, carbodiimide One or more of amines, genipin and polyglycol glyceryl ether.
优选的,所述交联剂的质量为丝素蛋白溶液中丝素蛋白质量的B%,B≥20。Preferably, the mass of the cross-linking agent is B% of the mass of silk fibroin in the silk fibroin solution, and B≥20.
优选的,所述步骤S1)中反应的时间为10~30min。Preferably, the reaction time in the step S1) is 10-30 minutes.
优选的,所述透析的时间为12~48h。Preferably, the dialysis time is 12-48 hours.
优选的,所述水蛭素溶液中水蛭素的浓度为C U/ml,0<C≤500。Preferably, the concentration of hirudin in the hirudin solution is C U/ml, 0<C≤500.
优选的,所述步骤S2)中浸渍的时间为2~10h。Preferably, the soaking time in the step S2) is 2-10 hours.
优选的,包括经聚乙二醇二胺离子化的丝素蛋白与水蛭素。Preferably, silk fibroin and hirudin ionized with polyethylene glycol diamine are included.
本发明提供了一种丝素蛋白抗凝血材料的制备方法,包括以下步骤:S1)将丝素蛋白溶液、聚乙二醇二胺与交联剂混合,反应后透析,干燥,得到聚乙二醇二胺阳离子化的丝素蛋白材料;S2)将所述聚乙二醇二胺阳离子化的丝素蛋白材料浸渍于水蛭素溶液中,得到丝素蛋白抗凝血材料。与现有技术相比,本发明提供的制备方法保护了与凝血酶结合区域的官能团(-COOH、-NH2、-OH)不因被反应而影响与凝血酶结合的结构域、又能使水蛭素以较强结合力的离子键结合于聚乙二醇双胺阳离子化的丝素蛋白上,达到稳定发挥抗凝的作用,从而使得到的丝素蛋白抗凝血材料具有显著抑制凝血酶活性的功能,尤其可应用于防止如人工血管的新生内膜增生和术后血栓的形成。The invention provides a preparation method of a silk fibroin anticoagulant material, comprising the following steps: S1) mixing a silk fibroin solution, polyethylene glycol diamine and a cross-linking agent, dialyzing after the reaction, and drying to obtain a polyethylene glycol diamine Silk fibroin material cationized with diol diamine; S2) The silk fibroin material cationized with polyethylene glycol diamine is immersed in a hirudin solution to obtain a silk fibroin anticoagulant material. Compared with the prior art, the preparation method provided by the present invention protects the functional groups (-COOH, -NH 2 , -OH) in the binding region to thrombin from being reacted to affect the binding domain to thrombin, and enables Hirudin binds to polyethylene glycol diamine cationized silk fibroin with a strong ionic bond to achieve a stable anticoagulant effect, so that the obtained silk fibroin anticoagulant material can significantly inhibit thrombin The active function can be especially applied to prevent the neointimal hyperplasia of artificial blood vessels and the formation of postoperative thrombus.
具体实施方式detailed description
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
本发明提供了一种丝素蛋白抗凝血材料,包括经聚乙二醇二胺与交联剂阳离子化的丝素蛋白与水蛭素。The invention provides a silk fibroin anticoagulant material, which comprises silk fibroin and hirudin cationized by polyethylene glycol diamine and a cross-linking agent.
其中,所述聚乙二醇二胺与丝素蛋白的质量比优选为A,0<A≤0.5,更优选为0.01~0.5,再优选为0.01~0.2,最优选为0.05~0.1;在本发明提供的一些实施例中,所述聚乙二醇二胺与丝素蛋白的质量比优选为0.01;在本发明提供的一些实施例中,所述聚乙二醇二胺与丝素蛋白的质量比优选为0.05;在本发明提供的另一些实施例中,所述聚乙二醇二胺与丝素蛋白的质量比优选为0.1。Wherein, the mass ratio of polyethylene glycol diamine to silk fibroin is preferably A, 0<A≤0.5, more preferably 0.01-0.5, more preferably 0.01-0.2, most preferably 0.05-0.1; In some embodiments provided by the invention, the mass ratio of polyethylene glycol diamine to silk fibroin is preferably 0.01; in some embodiments provided by the invention, the mass ratio of polyethylene glycol diamine to silk fibroin The mass ratio is preferably 0.05; in other embodiments provided by the present invention, the mass ratio of polyethylene glycol diamine to silk fibroin is preferably 0.1.
所述交联剂为本领域技术人员熟知的交联剂即可,并无特殊的限制,本发明中优选为-(3-二甲氨基丙基)-3-乙基碳二亚胺、N-羟基琥珀酰亚胺、2-吗啉乙磺酸、碳化二亚胺、京尼平与聚乙二醇甘油醚中的一种或多种;所述交联剂的质量优选为丝素蛋白质量的B%,B≥20,更优选为20%~50%。The cross-linking agent is a cross-linking agent well-known to those skilled in the art, and there is no special limitation. In the present invention, it is preferably -(3-dimethylaminopropyl)-3-ethylcarbodiimide, N - one or more of hydroxysuccinimide, 2-morpholineethanesulfonic acid, carbodiimide, genipin and macrogol glyceryl ether; the quality of the cross-linking agent is preferably silk fibroin The amount of B%, B ≥ 20, more preferably 20% to 50%.
本发明还提供了一种上述丝素蛋白抗凝血材料的制备方法,包括以下步骤:S1)将丝素蛋白溶液、聚乙二醇二胺与交联剂混合,反应后透析,干燥,得到聚乙二醇二胺阳离子化的丝素蛋白材料;S2)将所述聚乙二醇二胺阳离子化的丝素蛋白材料浸渍于水蛭素溶液中,得到丝素蛋白抗凝血材料。The present invention also provides a preparation method of the above-mentioned silk fibroin anticoagulant material, comprising the following steps: S1) mixing the silk fibroin solution, polyethylene glycol diamine and a cross-linking agent, dialyzing after the reaction, and drying to obtain Polyethylene glycol diamine cationized silk fibroin material; S2) The polyethylene glycol diamine cationized silk fibroin material was soaked in a hirudin solution to obtain a silk fibroin anticoagulant material.
本发明对所有原料的来源并没有特殊的限制,为市售或自制均可。The present invention has no special limitation on the sources of all raw materials, which can be commercially available or self-made.
其中,所述丝素蛋白溶液中丝素蛋白的质量浓度优选为3%~20%;所述丝素蛋白为本领域技术人员熟知的丝素蛋白即可,并无特殊的限制,本发明中优选为家蚕丝素蛋白;所述丝素蛋白溶液优选按照以下方法制备:将蚕丝或蚕壳进行脱胶、溶解后,灌注于透析袋内,用去离子水透析,得到丝素蛋白溶液。Wherein, the mass concentration of silk fibroin in the silk fibroin solution is preferably 3% to 20%; the silk fibroin can be silk fibroin well-known to those skilled in the art, and there is no special limitation. It is preferably silkworm silk fibroin; the silk fibroin solution is preferably prepared according to the following method: degumming and dissolving silk or silkworm shells, pouring them into a dialysis bag, and dialysis with deionized water to obtain a silk fibroin solution.
其中,所述脱胶的方法为本领域技术人员熟知的方法即可,并无特殊的限制,本发明中优选将蚕丝或蚕壳在碳酸钠水溶液中加热处理,水洗,拉松后,得到脱胶的丝素纤维;所述碳酸钠水溶液为本领域技术人员熟知的水溶液即可,并无特殊的限制,本发明中优选为浓度0.1%~1%的碳酸钠水溶液,更优选为0.1%~0.5%,再优选为0.2%~0.3%;所述蚕丝或蚕壳与碳酸钠水溶液的比例优选为(0.1~10)g:50ml,更优选为(0.5~5)g:50ml,再优选为(0.5~2)g:50ml,最优选为1g:50ml;所述加热处理的温度优选为98℃~100℃;所述加热处理的时间优选为20~40min;所述加热处理的次数优选为2~4次。Wherein, the degumming method is a method well known to those skilled in the art, and there is no special limitation. In the present invention, silk or silkworm shells are preferably heated in an aqueous solution of sodium carbonate, washed with water, and loosened to obtain degummed silk or silkworm shells. Silk fiber; the sodium carbonate aqueous solution is an aqueous solution well known to those skilled in the art, and there is no special limitation. In the present invention, it is preferably an aqueous sodium carbonate solution with a concentration of 0.1% to 1%, more preferably 0.1% to 0.5%. , more preferably 0.2%~0.3%; the ratio of described silk or silkworm shell and sodium carbonate aqueous solution is preferably (0.1~10) g: 50ml, more preferably (0.5~5) g: 50ml, more preferably (0.5 ~2) g: 50ml, most preferably 1g: 50ml; the temperature of the heat treatment is preferably 98°C~100°C; the time of the heat treatment is preferably 20~40min; the number of times of the heat treatment is preferably 2~ 4 times.
将脱胶的丝素纤维溶解,得到丝素溶解液;所述溶解的方法为本领域技术人员熟知的方法即可,并无特殊的限制,本发明中优选为将脱胶的丝素纤维与于氯化钙-乙醇的水溶液混合,加热溶解后,得到丝素溶解液;所述脱胶的丝素纤维与氯化钙-乙醇的水溶液的比例优选为(0.1~5)g:10ml,更优选为(0.5~3)g:10ml,再优选为(1~2)g:10ml;所述氯化钙与乙醇的摩尔比优选为1:2;所述加热溶解的温度优选为60℃~80℃,更优选为65℃~75℃,最优选为70℃;所述加热溶解的时间优选为1~3h,更优选为2~3h。Dissolving the degummed silk fibroin fiber to obtain a silk fibroin solution; the dissolving method is a method well known to those skilled in the art, and there is no special limitation. In the present invention, the degummed silk fibroin fiber is preferably mixed with chlorine The aqueous solution of calcium chloride-ethanol is mixed, and after heating and dissolving, silk fibroin solution is obtained; the ratio of the degummed silk fiber to the aqueous solution of calcium chloride-ethanol is preferably (0.1~5) g: 10ml, more preferably ( 0.5-3) g: 10 ml, more preferably (1-2) g: 10 ml; the molar ratio of calcium chloride to ethanol is preferably 1:2; the temperature for heating and dissolving is preferably 60°C-80°C, It is more preferably 65° C. to 75° C., most preferably 70° C.; the time for heating and dissolving is preferably 1 to 3 hours, more preferably 2 to 3 hours.
将丝素溶解液灌注于透析袋内,用去离子水透析,得到丝素蛋白溶液;所述透析袋为半透膜,其截留分子量优选为12.0~16.0kDa;透析时优选每隔1~3h,更优选每隔2h用新的去离子水或纯净水更换透析所用的去离子水;所述透析的时间优选为3天。Pour the silk fibroin solution into the dialysis bag, and dialyze with deionized water to obtain a silk fibroin solution; the dialysis bag is a semipermeable membrane, and its molecular weight cut-off is preferably 12.0-16.0kDa; during dialysis, preferably every 1-3h , more preferably replace the deionized water used for dialysis with new deionized water or purified water every 2h; the time of the dialysis is preferably 3 days.
将丝素蛋白溶液、聚乙二醇二胺与交联剂混合,优选先将丝素蛋白溶液与聚乙二醇二胺混合后,再加入交联剂;所述聚乙二醇二胺的质量与丝素蛋白溶液中丝素蛋白的质量比优选为A,0<A≤0.5,更优选为0.01~0.5,再优选为0.01~0.2,最优选为0.05~0.1;所述交联剂为本领域技术人员熟知的交联剂即可,并无特殊的限制,本发明中优选为1-(3-二甲氨基丙基)-3-乙基碳二亚胺、N-羟基琥珀酰亚胺、2-吗啉乙磺酸、碳化二亚胺、京尼平与聚乙二醇甘油醚中的一种或多种,更优选为1-(3-二甲氨基丙基)-3-乙基碳二亚胺、N-羟基琥珀酰亚胺与2-吗啉乙磺酸;所述1-(3-二甲氨基丙基)-3-乙基碳二亚胺、N-羟基琥珀酰亚胺与2-吗啉乙磺酸的质量比优选为2:1:2;所述交联剂的质量优选为丝素蛋白溶液中丝素蛋白质量的B%,B≥20,更优选为20%~50%。Mix the silk fibroin solution, polyethylene glycol diamine and a cross-linking agent, preferably first mix the silk fibroin solution and polyethylene glycol diamine, and then add the cross-linking agent; the polyethylene glycol diamine The mass ratio of mass to silk fibroin in the silk fibroin solution is preferably A, 0<A≤0.5, more preferably 0.01-0.5, more preferably 0.01-0.2, most preferably 0.05-0.1; the crosslinking agent is A cross-linking agent well known to those skilled in the art can be used without any special limitation. In the present invention, it is preferably 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, N-hydroxysuccinimide One or more of amine, 2-morpholineethanesulfonic acid, carbodiimide, genipin and polyethylene glycol glyceryl ether, more preferably 1-(3-dimethylaminopropyl)-3- Ethylcarbodiimide, N-hydroxysuccinimide and 2-morpholineethanesulfonic acid; the 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, N-hydroxysuccinimide The mass ratio of imide to 2-morpholineethanesulfonic acid is preferably 2:1:2; the quality of the cross-linking agent is preferably B% of the silk fibroin in the silk fibroin solution, B≥20, more preferably 20% to 50%.
然后进行反应;所述反应的时间优选为10min~1h,更优选为15~45min,再优选为20min。Then carry out the reaction; the reaction time is preferably 10 minutes to 1 hour, more preferably 15 to 45 minutes, and more preferably 20 minutes.
反应后透析;所述透析所用的半透膜的截留分子量优选为12.0~14.0kDa;所述透析的时间优选为12~48h,得到聚乙二醇二胺阳离子化的丝素蛋白溶液。Dialysis after the reaction; the molecular weight cut-off of the semipermeable membrane used in the dialysis is preferably 12.0-14.0 kDa; the time of the dialysis is preferably 12-48 hours to obtain a polyethylene glycol diamine cationized silk fibroin solution.
将聚乙二醇二胺阳离子化的丝素蛋白溶液干燥后,得到聚乙二醇二胺阳离子化的丝素蛋白材料;所述干燥可为加热干燥,也可为冷冻干燥;干燥时,优选将聚乙二醇二胺阳离子化的丝素蛋白溶液倒入平板内,再进行加热干燥或冷冻干燥;所述平板优选为聚苯乙烯板;所述加热干燥的温度优选为50℃~70℃。After the polyethylene glycol diamine cationized silk fibroin solution is dried, the polyethylene glycol diamine cationized silk fibroin material is obtained; the drying can be heat drying or freeze drying; during drying, preferably Pour the silk fibroin solution cationized with polyethylene glycol diamine into a flat plate, and then heat-dry or freeze-dry; the flat plate is preferably a polystyrene plate; the temperature of the heat-drying is preferably 50°C to 70°C .
将所述聚乙二醇二胺阳离子化的丝素蛋白材料浸渍于水蛭素溶液中;所述水蛭素溶液中水蛭素的浓度优选为C U/ml,0<C≤500,更优选为10~500U/ml,再优选为10~300U/ml,再优选为10~200U/ml,再优选为10~100U/ml,最优选为10~50U/ml;所述聚乙二醇二胺阳离子化的丝素蛋白材料与水蛭素溶液的比例优选为每毫克材料1~10ml水蛭素溶液,更优选为每毫克材料1~8ml水蛭素溶液,再优选为每毫克材料1~5ml水蛭素溶液,再优选为每毫克材料2~5ml水蛭素溶液,最优选为每毫克材料3ml水蛭素溶液;所述浸渍的时间优选为2~10h,更优选2~8h,再优选为4~6h,最优选为5h。The silk fibroin material cationized with polyethylene glycol diamine is immersed in a hirudin solution; the concentration of hirudin in the hirudin solution is preferably CU/ml, 0<C≤500, more preferably 10~ 500U/ml, more preferably 10-300U/ml, more preferably 10-200U/ml, more preferably 10-100U/ml, most preferably 10-50U/ml; the polyethylene glycol diamine cationization The ratio of the silk fibroin material and the hirudin solution is preferably 1 to 10 ml of the hirudin solution per milligram of the material, more preferably 1 to 8 ml of the hirudin solution per milligram of the material, more preferably 1 to 5 ml of the hirudin solution per milligram of the material, and then It is preferably 2~5ml hirudin solution per milligram of material, most preferably 3ml hirudin solution per milligram of material; the time of said soaking is preferably 2~10h, more preferably 2~8h, more preferably 4~6h, most preferably 5h.
浸渍后,优选取出风干,再用缓冲液冲洗,风干后,得到丝素蛋白抗凝血材料;所述缓冲液优选为磷酸盐缓冲液(PBS);所述冲洗的次数优选为3~4次。After dipping, it is preferable to take it out and air-dry it, and then rinse it with a buffer solution. After air-drying, the silk fibroin anticoagulant material is obtained; the buffer solution is preferably phosphate buffer saline (PBS); the number of times of the washing is preferably 3 to 4 times .
本发明提供的制备方法保护了与凝血酶结合区域的官能团(-COOH、-NH2、-OH)不因被反应而影响与凝血酶结合的结构域、又能使水蛭素以较强结合力的离子键结合于聚乙二醇双胺阳离子化的丝素蛋白上,达到稳定发挥抗凝的作用,从而使得到的丝素蛋白抗凝血材料具有显著抑制凝血酶活性的功能,尤其可应用于防止如人工血管的新生内膜增生和术后血栓的形成。The preparation method provided by the present invention protects the functional groups (-COOH, -NH 2 , -OH) of the binding region to thrombin from being reacted to affect the structural domain binding to thrombin, and enables hirudin to bind with stronger binding force. The ionic bond is combined with polyethylene glycol diamine cationized silk fibroin to achieve a stable anticoagulant effect, so that the obtained silk fibroin anticoagulant material has the function of significantly inhibiting the activity of thrombin, especially for the application of It is used to prevent the neointimal hyperplasia of artificial blood vessels and the formation of postoperative thrombus.
为了进一步说明本发明,以下结合实施例对本发明提供的一种丝素蛋白抗凝血材料及其制备方法进行详细描述。In order to further illustrate the present invention, a silk fibroin anticoagulant material provided by the present invention and its preparation method are described in detail below in conjunction with examples.
以下实施例中所用的试剂均为市售。The reagents used in the following examples are all commercially available.
实施例1Example 1
1.1将家蚕生丝或烘干分层的茧壳按1:50(g/mL)的浴比放入浓度为0.2%的碳酸钠水溶液中,于98℃~100℃处理三次,每次处理30分钟,然后用去离子水将丝充分清洗干净,拉松,置于60℃烘箱内干燥,得到脱胶后的家蚕丝素纤维。1.1 Put silkworm silk or cocoon shells dried and stratified into 0.2% aqueous sodium carbonate solution at a bath ratio of 1:50 (g/mL), and treat them three times at 98°C to 100°C, each time for 30 minutes , and then fully wash the silk with deionized water, loosen it, and place it in an oven at 60° C. to dry to obtain degummed silkworm silk fiber.
1.2称取脱胶后的家蚕丝素按1:10(g/mL)的浴比溶解于摩尔比1:2的氯化钙-乙醇的水溶液(乙醇与水的摩尔比1:4)中,70℃溶解2小时得家蚕丝素溶解液。1.2 Weigh the silkworm silk fibroin after degumming and dissolve it in an aqueous solution of calcium chloride-ethanol with a molar ratio of 1:2 (the molar ratio of ethanol to water is 1:4) at a bath ratio of 1:10 (g/mL), 70 ℃ for 2 hours to obtain silkworm fibroin solution.
1.3将家蚕丝素溶解液灌注于透析袋内,透析袋壁是半透膜,截留分子量为12.0~16.0kDa范围,将灌注了家蚕丝素溶解液的透析袋置于盛有去离子水的容器内,每隔2小时用新的去离子水或纯水更换容器内的水,持续透析3天,得到纯化后的家蚕丝素蛋白水溶液。调整透析后的丝素蛋白溶液浓度为4%。1.3 Pour the silkworm fibroin solution into the dialysis bag. The wall of the dialysis bag is a semi-permeable membrane with a molecular weight cut-off of 12.0-16.0kDa. Place the dialysis bag filled with the silkworm silk solution into a container filled with deionized water Inside, the water in the container was replaced with new deionized water or pure water every 2 hours, and the dialysis was continued for 3 days to obtain the purified aqueous silk fibroin protein solution. Adjust the concentration of silk fibroin solution after dialysis to 4%.
1.4按质量比100:1配置丝素蛋白与聚乙二醇二胺的混合溶液、搅拌均匀,向上述混合溶液中添加质量比为丝素蛋白20%的1-(3-二甲氨基丙基)-3-乙基碳二亚胺搅拌均匀、10%的N-羟基琥珀酰亚胺和20%的2-吗啉乙磺酸,反应20分钟后用去离子水透析12~48小时,得到聚乙二醇二胺阳离子化的丝素蛋白溶液,然后倒入一平整的聚苯乙烯板内60℃烘干得到聚乙二醇二胺阳离子化的丝素蛋白材料。1.4 Configure the mixed solution of silk fibroin and polyethylene glycol diamine according to the mass ratio of 100:1, stir evenly, add 1-(3-dimethylaminopropyl group whose mass ratio is 20% of silk fibroin to the above mixed solution )-3-ethylcarbodiimide was stirred evenly, 10% of N-hydroxysuccinimide and 20% of 2-morpholineethanesulfonic acid were reacted for 20 minutes and dialyzed with deionized water for 12 to 48 hours to obtain The polyethylene glycol diamine cationized silk fibroin solution is then poured into a flat polystyrene plate and dried at 60° C. to obtain the polyethylene glycol diamine cationized silk fibroin material.
1.5将聚乙二醇二胺阳离子化的丝素蛋白材料剪成一定面积的小片,按照每毫克材料3ml水蛭素溶液的比例浸渍于10U/mL的水蛭素溶液,5小时后取出静置风干后用PBS冲洗3~4次,最后风干,得到丝素蛋白抗凝血材料。1.5 Cut the silk fibroin material cationized with polyethylene glycol diamine into small pieces of a certain area, soak it in the hirudin solution of 10U/mL according to the ratio of 3ml hirudin solution per milligram of material, take it out after 5 hours and let it stand and air dry Rinse with PBS for 3 to 4 times, and finally air-dry to obtain silk fibroin anticoagulant material.
将实施例1制备的丝素蛋白抗凝血材料进行抗凝血酶活性测试,检测450nm处凝血酶活性的吸光度值为纯凝血酶活性的吸光度值的80%左右,即丝素蛋白抗凝血材料对凝血酶的活性有一定的抑制作用,说明水蛭素能够较好地结合于丝素蛋白材料上了。The silk fibroin anticoagulant material prepared in Example 1 was tested for antithrombin activity, and the absorbance value of thrombin activity at 450 nm was about 80% of that of pure thrombin activity, that is, silk fibroin anticoagulant The material has a certain inhibitory effect on the activity of thrombin, indicating that hirudin can be better combined with the silk fibroin material.
实施例2Example 2
2.1将家蚕生丝或烘干分层的茧壳按1:50(g/mL)的浴比放入浓度为0.2%的碳酸钠水溶液中,于98℃~100℃处理三次,每次处理30分钟,然后用去离子水将丝充分清洗干净,拉松,置于60℃烘箱内干燥,得到脱胶后的家蚕丝素纤维。2.1 Put silkworm silk or cocoon shells dried and stratified into 0.2% aqueous sodium carbonate solution at a bath ratio of 1:50 (g/mL), and treat them three times at 98°C to 100°C, each time for 30 minutes , and then fully wash the silk with deionized water, loosen it, and place it in an oven at 60° C. to dry to obtain degummed silkworm silk fiber.
2.2称取脱胶后的家蚕丝素按1:10(g/mL)的浴比溶解于摩尔比1:2的氯化钙-乙醇的水溶液(乙醇与水的摩尔比1:4)中,70℃溶解2小时得家蚕丝素溶解液。2.2 Weigh the degummed silkworm silk fibroin and dissolve it in an aqueous solution of calcium chloride-ethanol with a molar ratio of 1:2 (the molar ratio of ethanol to water is 1:4) at a bath ratio of 1:10 (g/mL), 70 ℃ for 2 hours to obtain silkworm fibroin solution.
2.3将家蚕丝素溶解液灌注于透析袋内,透析袋壁是半透膜,截留分子量为12.0~16.0kDa范围,将灌注了家蚕丝素溶解液的透析袋置于盛有去离子水的容器内,每隔2小时用新的去离子水或纯水更换容器内的水,持续透析3天,得到纯化后的家蚕丝素蛋白水溶液。调整透析后的丝素蛋白溶液浓度为4%。2.3 Pour the silkworm fibroin solution into the dialysis bag. The wall of the dialysis bag is a semi-permeable membrane with a molecular weight cut-off of 12.0-16.0kDa. Place the dialysis bag filled with the silkworm silk solution into a container filled with deionized water Inside, the water in the container was replaced with new deionized water or pure water every 2 hours, and the dialysis was continued for 3 days to obtain the purified aqueous silk fibroin protein solution. Adjust the concentration of silk fibroin solution after dialysis to 4%.
2.4按质量比100:5配置丝素蛋白与聚乙二醇二胺的混合溶液、搅拌均匀,向上述混合溶液中添加质量比为丝素蛋白20%的1-(3-二甲氨基丙基)-3-乙基碳二亚胺搅拌均匀、10%的N-羟基琥珀酰亚胺和20%的2-吗啉乙磺酸,反应20分钟后用去离子水透析12-48小时,得到聚乙二醇二胺阳离子化的丝素蛋白溶液,然后倒入一平整的聚苯乙烯板内60℃烘干得到聚乙二醇二胺阳离子化的丝素蛋白材料。2.4 Configure the mixed solution of silk fibroin and polyethylene glycol diamine according to the mass ratio of 100:5, stir evenly, and add 1-(3-dimethylaminopropyl group whose mass ratio is 20% of silk fibroin to the above mixed solution. )-3-ethylcarbodiimide was stirred evenly, 10% of N-hydroxysuccinimide and 20% of 2-morpholineethanesulfonic acid were reacted for 20 minutes and dialyzed with deionized water for 12-48 hours to obtain The polyethylene glycol diamine cationized silk fibroin solution is then poured into a flat polystyrene plate and dried at 60° C. to obtain the polyethylene glycol diamine cationized silk fibroin material.
2.5将聚乙二醇二胺阳离子化的丝素蛋白材料剪成一定面积的小片,按照每毫克材料3ml水蛭素溶液的比例浸渍于10U/mL的水蛭素溶液,5小时后取出静置风干后用PBS冲洗3~4次,最后风干,得到丝素蛋白抗凝血材料。2.5 Cut the silk fibroin material cationized with polyethylene glycol diamine into small pieces of a certain area, dip it in the hirudin solution of 10U/mL according to the ratio of 3ml hirudin solution per mg of material, take it out after 5 hours and let it dry in the air Rinse with PBS for 3 to 4 times, and finally air-dry to obtain silk fibroin anticoagulant material.
将实施例2制备的丝素蛋白抗凝血材料进行抗凝血酶活性测试,检测450nm处凝血酶活性的吸光度值为纯凝血酶活性的吸光度值的45%左右,即将实施例2制备的丝素蛋白抗凝血材料能够明显地抑制凝血酶的活性,说明水蛭素牢固地结合于丝素蛋白材料上了。The silk fibroin anticoagulant material prepared in Example 2 was tested for antithrombin activity, and the absorbance value of thrombin activity at 450 nm was about 45% of that of pure thrombin activity, that is, the silk fibroin prepared in Example 2 The fibroin anticoagulant material can obviously inhibit the activity of thrombin, indicating that hirudin is firmly bound to the silk fibroin material.
实施例3Example 3
3.1将家蚕生丝或烘干分层的茧壳按1:50(g/mL)的浴比放入浓度为0.2%的碳酸钠水溶液中,于98~100℃处理三次,每次处理30分钟,然后用去离子水将丝充分清洗干净,拉松,置于60℃烘箱内干燥,得到脱胶后的家蚕丝素纤维。3.1 Put silkworm raw silk or cocoon shells dried and layered into 0.2% sodium carbonate aqueous solution at a bath ratio of 1:50 (g/mL), and treat them three times at 98-100°C for 30 minutes each time. Then, the silk is fully cleaned with deionized water, loosened, and dried in an oven at 60° C. to obtain degummed silkworm silk fiber.
3.2称取脱胶后的家蚕丝素按1:10(g/mL)的浴比溶解于摩尔比1:2的氯化钙-乙醇的水溶液(乙醇与水的摩尔比1:4)中,70℃溶解2小时得家蚕丝素溶解液。3.2 Weigh the degummed silkworm silk fibroin and dissolve it in an aqueous solution of calcium chloride-ethanol with a molar ratio of 1:2 (the molar ratio of ethanol to water is 1:4) at a bath ratio of 1:10 (g/mL), 70 ℃ for 2 hours to obtain silkworm fibroin solution.
3.3将家蚕丝素溶解液灌注于透析袋内,透析袋壁是半透膜,截留分子量为12.0~16.0kDa范围,将灌注了家蚕丝素溶解液的透析袋置于盛有去离子水的容器内,每隔2小时用新的去离子水或纯水更换容器内的水,持续透析3天,得到纯化后的家蚕丝素蛋白水溶液。调整透析后的丝素蛋白溶液浓度为5%。3.3 Pour silkworm fibroin solution into the dialysis bag. The wall of the dialysis bag is a semipermeable membrane with a molecular weight cut-off of 12.0-16.0kDa. Place the dialysis bag filled with silkworm silk solution into a container filled with deionized water. Inside, the water in the container was replaced with new deionized water or pure water every 2 hours, and the dialysis was continued for 3 days to obtain the purified aqueous silk fibroin protein solution. Adjust the concentration of silk fibroin solution after dialysis to 5%.
3.4按质量比100:5配置丝素蛋白与聚乙二醇二胺的混合溶液、搅拌均匀,向上述混合溶液中添加质量比为丝素蛋白20%的1-(3-二甲氨基丙基)-3-乙基碳二亚胺搅拌均匀、10%的N-羟基琥珀酰亚胺和20%的2-吗啉乙磺酸,反应20分钟后用去离子水透析12~48小时,得到聚乙二醇二胺阳离子化的丝素蛋白溶液,然后倒入一平整的聚苯乙烯板内冷冻干燥得到聚乙二醇二胺阳离子化的丝素蛋白材料。3.4 Configure the mixed solution of silk fibroin and polyethylene glycol diamine according to the mass ratio of 100:5, stir evenly, and add 1-(3-dimethylaminopropyl group whose mass ratio is 20% of silk fibroin to the above mixed solution. )-3-ethylcarbodiimide was stirred evenly, 10% of N-hydroxysuccinimide and 20% of 2-morpholineethanesulfonic acid were reacted for 20 minutes and dialyzed with deionized water for 12 to 48 hours to obtain The polyethylene glycol diamine cationized silk fibroin solution is then poured into a flat polystyrene plate and freeze-dried to obtain the polyethylene glycol diamine cationized silk fibroin material.
3.5将阳离子化的再生丝素材料剪成一定面积的小片,按照每毫克材料3ml水蛭素溶液的比例浸渍于20U/mL的水蛭素溶液,5小时后取出静置风干后用PBS冲洗3~4次,最后风干,得到丝素蛋白抗凝血材料。3.5 Cut the cationized regenerated silk fibroin material into small pieces of a certain area, dip in 20U/mL hirudin solution at a ratio of 3ml hirudin solution per milligram of material, take it out after 5 hours, let it stand and air-dry, and rinse with PBS for 3-4 hours. times, and finally air-dried to obtain silk fibroin anticoagulant material.
将实施例3制备的丝素蛋白抗凝血材料进行抗凝血酶活性测试,检测450nm处凝血酶活性的吸光度值为纯凝血酶活性的吸光度值的33%左右,即加丝素蛋白抗凝血材料能够显著地抑制凝血酶的活性,说明水蛭素牢固地结合于丝素蛋白材料上了。The silk fibroin anticoagulant material prepared in Example 3 is tested for antithrombin activity, and the absorbance value of thrombin activity at 450 nm is about 33% of that of pure thrombin activity, that is, adding silk fibroin for anticoagulation The blood material can significantly inhibit the activity of thrombin, indicating that hirudin is firmly bound to the silk fibroin material.
实施例4Example 4
4.1将家蚕生丝或烘干分层的茧壳按1:50(g/mL)的浴比放入浓度为0.2%的碳酸钠水溶液中,于98~100℃处理三次,每次处理30分钟,然后用去离子水将丝充分清洗干净,拉松,置于60℃烘箱内干燥,得到脱胶后的家蚕丝素纤维。4.1 Put silkworm raw silk or cocoon shells dried and layered into 0.2% sodium carbonate aqueous solution at a bath ratio of 1:50 (g/mL), and treat them three times at 98-100°C for 30 minutes each time. Then, the silk is fully cleaned with deionized water, loosened, and dried in an oven at 60° C. to obtain degummed silkworm silk fiber.
4.2称取脱胶后的家蚕丝素按1:10(g/mL)的浴比溶解于摩尔比1:2的氯化钙-乙醇的水溶液(乙醇与水的摩尔比1:4)中,70℃溶解2小时得家蚕丝素溶解液。4.2 Weigh the degummed silkworm silk fibroin and dissolve it in an aqueous solution of calcium chloride-ethanol with a molar ratio of 1:2 (the molar ratio of ethanol to water is 1:4) at a bath ratio of 1:10 (g/mL), 70 ℃ for 2 hours to obtain silkworm fibroin solution.
4.3将家蚕丝素溶解液灌注于透析袋内,透析袋壁是半透膜,截留分子量为12.0~16.0kDa范围,将灌注了家蚕丝素溶解液的透析袋置于盛有去离子水的容器内,每隔2小时用新的去离子水或纯水更换容器内的水,持续透析3天,得到纯化后的家蚕丝素蛋白水溶液。调整透析后的丝素蛋白溶液浓度为5%。4.3 Pour the silkworm fibroin solution into the dialysis bag. The wall of the dialysis bag is a semi-permeable membrane with a molecular weight cut-off of 12.0-16.0kDa. Place the dialysis bag filled with the silkworm solution into a container filled with deionized water. Inside, the water in the container was replaced with new deionized water or pure water every 2 hours, and the dialysis was continued for 3 days to obtain the purified aqueous silk fibroin protein solution. Adjust the concentration of silk fibroin solution after dialysis to 5%.
4.4按质量比100:10配置丝素蛋白与聚乙二醇二胺的混合溶液、搅拌均匀,向上述混合溶液中添加质量比为丝素蛋白20%的1-(3-二甲氨基丙基)-3-乙基碳二亚胺搅拌均匀、10%的N-羟基琥珀酰亚胺和20%的2-吗啉乙磺酸,反应20分钟后用去离子水透析12~48小时,得到聚乙二醇二胺阳离子化的丝素蛋白溶液,然后倒入一平整的聚苯乙烯板内冷冻干燥得到聚乙二醇二胺阳离子化的丝素蛋白材料。4.4 Configure the mixed solution of silk fibroin and polyethylene glycol diamine according to the mass ratio of 100:10, stir evenly, and add 1-(3-dimethylaminopropyl group whose mass ratio is 20% of silk fibroin to the above mixed solution. )-3-ethylcarbodiimide was stirred evenly, 10% of N-hydroxysuccinimide and 20% of 2-morpholineethanesulfonic acid were reacted for 20 minutes and dialyzed with deionized water for 12 to 48 hours to obtain The polyethylene glycol diamine cationized silk fibroin solution is then poured into a flat polystyrene plate and freeze-dried to obtain the polyethylene glycol diamine cationized silk fibroin material.
4.5将聚乙二醇二胺阳离子化的丝素蛋白材料剪成一定面积的小片,按照每毫克材料3ml水蛭素溶液的比例浸渍于40U/mL的水蛭素溶液,5小时后取出静置风干后用PBS冲洗3~4次,最后风干,得到丝素蛋白抗凝血材料。4.5 Cut the polyethylene glycol diamine cationized silk fibroin material into small pieces of a certain area, dip it in a 40U/mL hirudin solution at a ratio of 3ml hirudin solution per milligram of material, take it out after 5 hours and let it stand and air dry Rinse with PBS for 3 to 4 times, and finally air-dry to obtain silk fibroin anticoagulant material.
将实施例4制备的丝素蛋白抗凝血材料进行抗凝血酶活性测试,检测450nm处凝血酶活性的吸光度值为纯凝血酶活性的吸光度值的10%以下,即实施例4得到的丝素蛋白抗凝血材料能够显著地抑制凝血酶的活性,说明更多的水蛭素牢固地结合于丝素蛋白材料上了。The silk fibroin anticoagulant material prepared in Example 4 was tested for antithrombin activity, and the absorbance value of thrombin activity at 450 nm was less than 10% of that of pure thrombin activity, that is, the silk fibroin obtained in Example 4 The fibroin anticoagulant material can significantly inhibit the activity of thrombin, indicating that more hirudin is firmly bound to the silk fibroin material.
比较例1Comparative example 1
1.1将家蚕生丝或烘干分层的茧壳按1:50(g/mL)的浴比放入浓度为0.2%的碳酸钠水溶液中,于98~100℃处理三次,每次处理30分钟,然后用去离子水将丝充分清洗干净,拉松,置于60℃烘箱内干燥,得到脱胶后的家蚕丝素纤维。1.1 Put silkworm raw silk or cocoon shells dried and layered into 0.2% aqueous sodium carbonate solution at a bath ratio of 1:50 (g/mL), and treat them three times at 98-100°C for 30 minutes each time. Then, the silk is fully cleaned with deionized water, loosened, and dried in an oven at 60° C. to obtain degummed silkworm silk fiber.
1.2称取脱胶后的家蚕丝素按1:10(g/mL)的浴比溶解于摩尔比1:2的氯化钙-乙醇的水溶液(乙醇与水的摩尔比1:4)中,70℃溶解2小时得家蚕丝素溶解液。1.2 Weigh the silkworm silk fibroin after degumming and dissolve it in an aqueous solution of calcium chloride-ethanol with a molar ratio of 1:2 (the molar ratio of ethanol to water is 1:4) at a bath ratio of 1:10 (g/mL), 70 ℃ for 2 hours to obtain silkworm fibroin solution.
1.3将家蚕丝素溶解液灌注于透析袋内,透析袋壁是半透膜,截留分子量为12.0~16.0kDa范围,将灌注了家蚕丝素溶解液的透析袋置于盛有去离子水的容器内,每隔2小时用新的去离子水或纯水更换容器内的水,持续透析3天,得到纯化后的家蚕丝素蛋白水溶液。调整透析后的丝素蛋白溶液浓度为5%。1.3 Pour the silkworm fibroin solution into the dialysis bag. The wall of the dialysis bag is a semi-permeable membrane with a molecular weight cut-off of 12.0-16.0kDa. Place the dialysis bag filled with the silkworm silk solution into a container filled with deionized water Inside, the water in the container was replaced with new deionized water or pure water every 2 hours, and the dialysis was continued for 3 days to obtain the purified aqueous silk fibroin protein solution. Adjust the concentration of silk fibroin solution after dialysis to 5%.
1.4向丝素蛋白水溶液中加入质量比为丝素蛋白20%的1-(3-二甲氨基丙基)-3-乙基碳二亚胺搅拌均匀、10%的N-羟基琥珀酰亚胺和20%的2-吗啉乙磺酸,搅拌20分钟后用去离子水透析12~48小时,然后倒入一平整的聚苯乙烯板内冷冻干燥得再生丝素材料。1.4 Add 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide with a mass ratio of 20% silk fibroin to the silk fibroin aqueous solution and stir evenly, 10% N-hydroxysuccinimide and 20% 2-morpholineethanesulfonic acid, stirred for 20 minutes, dialyzed with deionized water for 12 to 48 hours, then poured into a flat polystyrene plate and freeze-dried to obtain the regenerated silk fibroin material.
1.5将纯的再生丝素材料剪成一定面积的小片,按照每毫克材料3ml水蛭素溶液的比例浸渍于20U/mL的水蛭素溶液,5小时后取出静置风干后用PBS冲洗3~4次,最后风干,得到加载水蛭素的丝素材料。1.5 Cut the pure regenerated silk fibroin material into small pieces of a certain area, dip in the hirudin solution of 20U/mL according to the ratio of 3ml hirudin solution per milligram of material, take it out after 5 hours, let it stand and air-dry, and rinse it with PBS for 3-4 times , and finally air-dried to obtain hirudin-loaded silk fibroin material.
将制备好的加载水蛭素的丝素材料进行抗凝血酶活性测试,检测450nm处凝血酶活性的吸光度值为纯凝血酶活性的吸光度值的96%以上,即加载水蛭素的丝素蛋白材料没有能有效地抑制凝血酶的活性,说明水蛭素没有被牢固地加载到丝素蛋白材料上。The prepared hirudin-loaded silk fibroin material was tested for antithrombin activity, and the absorbance value of the thrombin activity at 450 nm was more than 96% of that of pure thrombin activity, that is, the hirudin-loaded silk fibroin material There was no effective inhibition of thrombin activity, indicating that hirudin was not firmly loaded onto the silk fibroin material.
比较例2Comparative example 2
2.1将家蚕生丝或烘干分层的茧壳按1:50(g/mL)的浴比放入浓度为0.2%的碳酸钠水溶液中,于98~100℃处理三次,每次处理30分钟,然后用去离子水将丝充分清洗干净,拉松,置于60℃烘箱内干燥,得到脱胶后的家蚕丝素纤维。2.1 Put silkworm raw silk or cocoon shells dried and layered into 0.2% sodium carbonate aqueous solution at a bath ratio of 1:50 (g/mL), and treat them three times at 98-100°C for 30 minutes each time. Then, the silk is fully cleaned with deionized water, loosened, and dried in an oven at 60° C. to obtain degummed silkworm silk fiber.
2.2称取脱胶后的家蚕丝素按1:10(g/mL)的浴比溶解于摩尔比1:2的氯化钙-乙醇的水溶液(乙醇与水的摩尔比1:4)中,70℃溶解2小时得家蚕丝素溶解液。2.2 Weigh the degummed silkworm silk fibroin and dissolve it in an aqueous solution of calcium chloride-ethanol with a molar ratio of 1:2 (the molar ratio of ethanol to water is 1:4) at a bath ratio of 1:10 (g/mL), 70 ℃ for 2 hours to obtain silkworm fibroin solution.
2.3将家蚕丝素溶解液灌注于透析袋内,透析袋壁是半透膜,截留分子量为12.0~16.0kDa范围,将灌注了家蚕丝素溶解液的透析袋置于盛有去离子水的容器内,每隔2小时用新的去离子水或纯水更换容器内的水,持续透析3天,得到纯化后的家蚕丝素蛋白水溶液。调整透析后的丝素蛋白溶液浓度为5%。2.3 Pour the silkworm fibroin solution into the dialysis bag. The wall of the dialysis bag is a semi-permeable membrane with a molecular weight cut-off of 12.0-16.0kDa. Place the dialysis bag filled with the silkworm silk solution into a container filled with deionized water Inside, the water in the container was replaced with new deionized water or pure water every 2 hours, and the dialysis was continued for 3 days to obtain the purified aqueous silk fibroin protein solution. Adjust the concentration of silk fibroin solution after dialysis to 5%.
2.4向丝素蛋白水溶液中加入质量比为丝素蛋白20%的1-(3-二甲氨基丙基)-3-乙基碳二亚胺搅拌均匀、10%的N-羟基琥珀酰亚胺和20%的2-吗啉乙磺酸,搅拌20分钟后用去离子水透析12~48小时,然后倒入一平整的聚苯乙烯板内冷冻干燥得再生丝素材料。2.4 Add 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide with a mass ratio of 20% silk fibroin to the silk fibroin aqueous solution and stir evenly, 10% N-hydroxysuccinimide and 20% 2-morpholineethanesulfonic acid, stirred for 20 minutes, dialyzed with deionized water for 12 to 48 hours, then poured into a flat polystyrene plate and freeze-dried to obtain the regenerated silk fibroin material.
将制备好的再生丝素材料进行抗凝血酶活性测试,检测450nm处凝血酶活性的吸光度值为纯凝血酶活性的吸光度值的98%,即再生丝素材料没有抑制凝血酶活性的能力。The prepared regenerated silk fibroin material was tested for antithrombin activity, and the absorbance value of thrombin activity at 450 nm was 98% of that of pure thrombin activity, that is, the regenerated silk fibroin material had no ability to inhibit thrombin activity.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710108408.4A CN106730052B (en) | 2017-02-27 | 2017-02-27 | Silk fibroin anticoagulant material and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710108408.4A CN106730052B (en) | 2017-02-27 | 2017-02-27 | Silk fibroin anticoagulant material and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106730052A true CN106730052A (en) | 2017-05-31 |
| CN106730052B CN106730052B (en) | 2020-04-07 |
Family
ID=58959244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710108408.4A Active CN106730052B (en) | 2017-02-27 | 2017-02-27 | Silk fibroin anticoagulant material and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106730052B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110038162A (en) * | 2019-04-16 | 2019-07-23 | 苏州大学 | It is a kind of to have the function of modulating vascular cell growth effect silk fibroin material and preparation method thereof |
| CN112043877A (en) * | 2020-08-06 | 2020-12-08 | 苏州大学 | Silk anticoagulant tube stent tectorial membrane and preparation method thereof |
| CN112043878A (en) * | 2020-08-06 | 2020-12-08 | 苏州大学 | A kind of anticoagulant tube stent coating and preparation method thereof |
| CN114887123A (en) * | 2022-04-18 | 2022-08-12 | 南通大学 | Hirudin grafted nanofiber vascular stent material, preparation method and application |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6139433B2 (en) * | 1978-08-21 | 1986-09-03 | Kanebo Kenshi Kyobijin Kk | |
| CN103285431A (en) * | 2013-06-21 | 2013-09-11 | 苏州大学 | Anticoagulation fibroin material and preparation method thereof |
| CN103301506A (en) * | 2013-06-21 | 2013-09-18 | 苏州大学 | Anticoagulation fibroin membrane and preparation method thereof |
| US20140315828A1 (en) * | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| CN104524632A (en) * | 2015-01-21 | 2015-04-22 | 北京航空航天大学 | Preparation method of anti-coagulating composite tubular scaffold with good compliance |
-
2017
- 2017-02-27 CN CN201710108408.4A patent/CN106730052B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6139433B2 (en) * | 1978-08-21 | 1986-09-03 | Kanebo Kenshi Kyobijin Kk | |
| US20140315828A1 (en) * | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| CN103285431A (en) * | 2013-06-21 | 2013-09-11 | 苏州大学 | Anticoagulation fibroin material and preparation method thereof |
| CN103301506A (en) * | 2013-06-21 | 2013-09-18 | 苏州大学 | Anticoagulation fibroin membrane and preparation method thereof |
| CN104524632A (en) * | 2015-01-21 | 2015-04-22 | 北京航空航天大学 | Preparation method of anti-coagulating composite tubular scaffold with good compliance |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110038162A (en) * | 2019-04-16 | 2019-07-23 | 苏州大学 | It is a kind of to have the function of modulating vascular cell growth effect silk fibroin material and preparation method thereof |
| CN110038162B (en) * | 2019-04-16 | 2021-08-31 | 苏州大学 | A kind of functional silk fibroin material with the effect of regulating the growth of vascular cells and preparation method thereof |
| CN112043877A (en) * | 2020-08-06 | 2020-12-08 | 苏州大学 | Silk anticoagulant tube stent tectorial membrane and preparation method thereof |
| CN112043878A (en) * | 2020-08-06 | 2020-12-08 | 苏州大学 | A kind of anticoagulant tube stent coating and preparation method thereof |
| WO2022028396A1 (en) * | 2020-08-06 | 2022-02-10 | 苏州大学 | Silk anticoagulant vascular stent cover film and preparation method therefor |
| WO2022028395A1 (en) * | 2020-08-06 | 2022-02-10 | 苏州大学 | Anticoagulant intravascular stent cover film and preparation method therefor |
| CN114887123A (en) * | 2022-04-18 | 2022-08-12 | 南通大学 | Hirudin grafted nanofiber vascular stent material, preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106730052B (en) | 2020-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marcolin et al. | Electrospun silk fibroin–gelatin composite tubular matrices as scaffolds for small diameter blood vessel regeneration | |
| CN103301506B (en) | Anticoagulation fibroin membrane and preparation method thereof | |
| CN110025828B (en) | A kind of functional silk fibroin porous material or functional silk fibroin membrane and preparation method thereof | |
| CN103285431B (en) | Anticoagulation fibroin material and preparation method thereof | |
| CN107998450B (en) | Artificial skin and preparation method and application thereof | |
| CN111821514B (en) | A kind of silk fibroin sericin composite membrane and preparation method thereof | |
| CN106479195A (en) | A kind of nano-cellulose strengthens fibroin albumen composite material and preparation method thereof | |
| JP4551761B2 (en) | Keratin-derived orthopedic material | |
| CN106729984A (en) | A kind of Isin glue collagen repairs sponge and preparation method thereof | |
| CN106730052A (en) | A kind of anticoagulant fimbrin material and preparation method thereof | |
| CN106943632A (en) | A kind of collagen/chondroitin sulfate combined artificial cornea and preparation method thereof | |
| CN101264342A (en) | Silk fibroin small-bore blood vessels | |
| CN107118361B (en) | A kind of silk fibroin/carboxymethyl chitosan composite gel and preparation method thereof | |
| CN106693082B (en) | A kind of anticoagulant material and preparation method thereof | |
| CN110075309B (en) | Silk fibroin film with function of regulating and controlling growth of blood vessel cells and preparation method thereof | |
| CN110003518A (en) | A kind of activity silk fibroin porous material or active fibroin protein film and preparation method thereof | |
| CN111671980A (en) | A kind of bionic composite bone scaffold and preparation method thereof | |
| CN100382772C (en) | Preparation method of medical nerve graft containing silk fibroin | |
| CN111494712B (en) | Preparation method of silk fibroin nerve graft fused with NT3 | |
| CN103721300B (en) | Anticoagulation coating material and preparation method thereof | |
| CN101264337B (en) | Preparation of collagen base biological medical material | |
| CN106902398A (en) | Cationization fibroin material, its preparation method and application | |
| CN104017230A (en) | Preparation method of polyurethane-keratin composite film | |
| CN114949347B (en) | Modified crosslinked biological valve and preparation method and application thereof | |
| CN101559238A (en) | Method for preparing biodegradable blood vessel external scaffold material used in tissue engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |